Pharma & Biotech

Jazz Pharmaceuticals has achieved two significant regulatory milestones for its oncology therapeutic, Modeyso. The company obtained both an accelerated approval...

Biotech firm Akari Therapeutics finds itself navigating a severe financial crisis, marked by the abrupt departure of its chief financial...

Celularity Inc. finds itself navigating a critical period as it confronts potential delisting from the Nasdaq exchange. The biotechnology company...

The biotechnology firm Atara Biotherapeutics stands at a pivotal juncture. Following significant regulatory progress and unexpectedly strong quarterly earnings, the...

Eli Lilly stands poised to revolutionize obesity treatment with its experimental oral medication Orforglipron, following outstanding Phase 3 clinical trial...

Investors in Rockwell Medical experienced significant volatility as the dialysis product manufacturer's stock declined 5% on Friday. This pullback arrived...

A remarkable convergence of fundamental strength and technical indicators has propelled InfuSystem Holdings Inc. to impressive gains, with its equity...

Veeva Systems delivered a powerful quarterly performance that surpassed expectations, simultaneously announcing a landmark strategic alliance with biotechnology leader Amgen....

X4 Pharmaceuticals is undergoing a profound corporate transformation, marked by a complete overhaul of its executive leadership and the successful...

Dyne Therapeutics Inc finds itself at a pivotal crossroads as two significant events converge this week. The biotechnology firm, whose...